Eli Lilly Q2 2022 Earnings Conference Call On August 4, 2022 At 09:00 AM ET

Eli Lilly (NYSE:LLY) will host a conference call at 09:00 AM ET on August 4, 2022, to discuss Q2 2022 earnings results. How to Attend Eli Lilly (LLY) Conference Call Follow this link to access the live webcast.

Eli Lilly (NYSE:LLY) will host a conference call at 09:00 AM ET on August 4, 2022, to discuss Q2 2022 earnings results.

How to Attend Eli Lilly (LLY) Conference Call

Follow this link to access the live webcast.

To listen to the call, dial (US) or (International)

What Is an Earnings Conference Call?

Earnings conference calls allow companies to talk about their recent earnings reports publicly, so that anyone who is interested can get more information on what happened and why it happened.

During a call, a company will discuss future performance expectations as well as go over their quarterly financial results. Most investors have benefitted from listening closely to how management responds to questions, in order to get a feel for how confident they are in the company’s current and future performance.

If you want to take a deeper dive into Eli Lilly earnings, you can follow their earnings on Benzinga.

This article was generated by Benzinga’s automated content engine and reviewed by an editor

Total
0
Shares
Related Posts
Read More

Multi-Banner Cannabis Retailer’s Q3 Revenue Slumps Over 42% YoY But CEO Remains Optimistic

Shiny Health & Wellness Corp. has reported a decrease in sales to CA$ 4.3 million ($3.2m million) for the three months ending October 31, 2023, down from CA$ 7.46m the previous financial year. The decline was attributed to market trends in the Ontario cannabis retail sector throughout the period, the pharmaceutical company said. Shiny Health also closed underperforming adult-use cannabis dispensaries and sold a number of larger stores. The Toronto-based firm recently inked an agreement with Karan S. Holla for his chain of 10 adult-use cannabis retail outlets, Stash & Co. CEO Meris Kott said Shiny Health was gradually building its brand presence in Ontario. The pharma company revealed that it made a CA$ 6m net loss for the quarter, an uptick from the CA$ 1.75m loss in the corresponding period the year before.

TSXV:SNYB